DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $786,216 | -62.8% | 26,642 | -71.0% | 0.01% | -61.5% |
| Q1 2023 | $2,115,210 | +1471.5% | 91,806 | +1796.8% | 0.01% | +1200.0% |
| Q4 2022 | $134,600 | -88.6% | 4,840 | -87.4% | 0.00% | -85.7% |
| Q3 2022 | $1,177,000 | -44.4% | 38,341 | -46.7% | 0.01% | -46.2% |
| Q2 2022 | $2,116,000 | +306.9% | 71,904 | +344.7% | 0.01% | +225.0% |
| Q1 2022 | $520,000 | +48.1% | 16,169 | +105.6% | 0.00% | +33.3% |
| Q4 2021 | $351,000 | -27.6% | 7,866 | -18.1% | 0.00% | -50.0% |
| Q3 2021 | $485,000 | -59.0% | 9,606 | -36.2% | 0.01% | -53.8% |
| Q2 2021 | $1,182,000 | -75.3% | 15,068 | -82.0% | 0.01% | -78.7% |
| Q1 2021 | $4,776,000 | +165.8% | 83,641 | +290.0% | 0.06% | +144.0% |
| Q4 2020 | $1,797,000 | -42.7% | 21,449 | -75.5% | 0.02% | -45.7% |
| Q3 2020 | $3,138,000 | +530.1% | 87,569 | +325.3% | 0.05% | +411.1% |
| Q2 2020 | $498,000 | +21.2% | 20,590 | -12.4% | 0.01% | -18.2% |
| Q1 2020 | $411,000 | -15.1% | 23,499 | +12.8% | 0.01% | -31.2% |
| Q1 2019 | $484,000 | +163.0% | 20,840 | +77.0% | 0.02% | +60.0% |
| Q4 2017 | $184,000 | – | 11,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |